Combined influence of immigration status and income on cervical cancer screening uptake.
Cervical cancer screening
France
Migration status
Social inequalities
Journal
Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
19
09
2022
revised:
10
07
2023
accepted:
04
08
2023
medline:
21
9
2023
pubmed:
21
9
2023
entrez:
21
9
2023
Statut:
epublish
Résumé
The regular performance of Pap tests for cervical cancer screening reduces this disease's incidence and mortality. Income inequalities have been reported for this screening, partly because in some countries women must advance or even pay out-of-pocket costs. Because immigrant status is also associated with low Pap test uptake, we aimed to analyze the combined impact of immigrant status and low income on cervical cancer underscreening. This study, based on the French CONSTANCES cohort, uses data from the cohort questionnaires and linked health insurance fund data about Pap test reimbursement. To measure income inequalities in screening, we calculated a Slope Index of Inequality (SII) by linear regression, taking into account the migration status of participants. The majority of the 70,614 women included in the analysis were not immigrants (80.2%), while 12.9% were second-generation immigrants, and 6.9% first-generation immigrants. The proportion of underscreening increased with immigrant status, from 19.5% among nonimmigrants to 23.6% among the second generation, and 26.5% among the first (
Identifiants
pubmed: 37732022
doi: 10.1016/j.pmedr.2023.102363
pii: S2211-3355(23)00254-1
pmc: PMC10507147
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102363Informations de copyright
© 2023 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Eur J Cancer Prev. 2016 Nov;25(6):547-55
pubmed: 26628087
Int J Equity Health. 2020 Sep 11;19(1):160
pubmed: 32917224
Yonsei Med J. 2018 Nov;59(9):1026-1033
pubmed: 30328316
BMJ Open. 2019 Sep 27;9(9):e030216
pubmed: 31562151
Int J Epidemiol. 2010 Jun;39(3):757-65
pubmed: 20176587
Occup Environ Med. 2017 Jan;74(1):66-71
pubmed: 27884936
Health Place. 2010 Sep;16(5):838-52
pubmed: 20451439
Obes Res Clin Pract. 2021 May-Jun;15(3):212-215
pubmed: 33771444
Med Care. 2006 Aug;44(8):788-92
pubmed: 16862042
PLoS One. 2014 Jan 22;9(1):e87046
pubmed: 24466323
J Womens Health (Larchmt). 2007 Dec;16(10):1447-57
pubmed: 18062760
Epidemiology. 2015 Jul;26(4):518-27
pubmed: 26000548
Cancer Epidemiol. 2019 Feb;58:98-103
pubmed: 30530110
Eur J Cancer. 2008 Jul;44(10):1404-13
pubmed: 18343653
BMJ Open. 2017 Dec 14;7(12):e016941
pubmed: 29247085
Eur J Cancer Prev. 2015 May;24(3):223-30
pubmed: 25714783